JPS52139054A - Novel furan ringgcontaining tricyclic compounds and their preparation - Google Patents

Novel furan ringgcontaining tricyclic compounds and their preparation

Info

Publication number
JPS52139054A
JPS52139054A JP2974277A JP2974277A JPS52139054A JP S52139054 A JPS52139054 A JP S52139054A JP 2974277 A JP2974277 A JP 2974277A JP 2974277 A JP2974277 A JP 2974277A JP S52139054 A JPS52139054 A JP S52139054A
Authority
JP
Japan
Prior art keywords
ringgcontaining
preparation
tricyclic compounds
novel furan
furan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2974277A
Other languages
English (en)
Japanese (ja)
Inventor
Ibu Moberunei Rooran
Biyushie Norubeeru
Moreeiru Jiyatsuku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CT EUROP RUSHIERUSHIYU MOOBERU
Original Assignee
CT EUROP RUSHIERUSHIYU MOOBERU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CT EUROP RUSHIERUSHIYU MOOBERU filed Critical CT EUROP RUSHIERUSHIYU MOOBERU
Publication of JPS52139054A publication Critical patent/JPS52139054A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
JP2974277A 1976-03-17 1977-03-17 Novel furan ringgcontaining tricyclic compounds and their preparation Pending JPS52139054A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7607698A FR2344284A1 (fr) 1976-03-17 1976-03-17 Nouveaux composes tricycliques a cycle furannique et leur application comme antidepresseurs

Publications (1)

Publication Number Publication Date
JPS52139054A true JPS52139054A (en) 1977-11-19

Family

ID=9170573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2974277A Pending JPS52139054A (en) 1976-03-17 1977-03-17 Novel furan ringgcontaining tricyclic compounds and their preparation

Country Status (6)

Country Link
US (1) US4105785A (en:Method)
JP (1) JPS52139054A (en:Method)
CH (1) CH599191A5 (en:Method)
DE (1) DE2710971A1 (en:Method)
FR (1) FR2344284A1 (en:Method)
GB (1) GB1522457A (en:Method)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255445A (en) * 1980-03-07 1981-03-10 Smithkline Corporation 8-Hydroxy-6,7-(2-methyl-2,3-dihydrofuro)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
FR2493846A1 (fr) * 1980-11-10 1982-05-14 Delbarre B Derives du 4h-benzo(4,5)cyclohepta(1,2-b)furanne, leur procede de preparation et leur application en tant que medicaments
US5244920A (en) * 1985-04-15 1993-09-14 Schering Spa Pharmaceutical compositions having therapeutical activity based on mercaptoethansulphonic arginine salt
FR2613364B1 (fr) * 1987-04-01 1989-06-09 Adir Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2739855B1 (fr) * 1995-10-13 1997-11-14 Adir Nouvelles amines heterocycliques tertiaires, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2002096374A2 (en) 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
SE0102299D0 (sv) * 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
US20080312207A1 (en) * 2004-02-18 2008-12-18 Craig Johnstone Compounds
ES2322709T3 (es) * 2004-02-18 2009-06-25 Astrazeneca Ab Derivados de benzamida y su uso como agentes activadores de la glucocinasa.
TW200600086A (en) * 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
GB0423044D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
GB0423043D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
US7700640B2 (en) 2004-10-16 2010-04-20 Astrazeneca Ab Process for making phenoxy benzamide compounds
WO2006125958A1 (en) * 2005-05-24 2006-11-30 Astrazeneca Ab 2-phenyl substituted imidazol [4 , 5b] pyridine/ pyrazine and purine derivatives as glucokinase modulators
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
JP2009500442A (ja) * 2005-07-09 2009-01-08 アストラゼネカ アクチボラグ ２型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての２−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物
US20080234273A1 (en) * 2005-07-09 2008-09-25 Mckerrecher Darren Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
EP2305674A1 (en) * 2005-07-09 2011-04-06 AstraZeneca AB Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US9202182B2 (en) * 2005-08-11 2015-12-01 International Business Machines Corporation Method and system for analyzing business architecture
TW200738621A (en) * 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
TW200825063A (en) * 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
SA07280576B1 (ar) * 2006-10-26 2011-06-22 استرازينيكا ايه بي مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
UY30822A1 (es) * 2006-12-21 2008-07-31 Astrazeneca Ab Fnueva forma cristalina de 3-{[5-azetidin-1-ylcabonyl)pyrazin-2-yl]oxy}-5-[1-methylethyloxy]-n-1h-pyrazol-3-ylbenzamida, composiciones conteniéndola, procesos de preparacion y aplicaciones
EP2309858A4 (en) 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
CN102171213A (zh) * 2008-08-04 2011-08-31 阿斯利康(瑞典)有限公司 吡唑并[3，4]嘧啶-4-基衍生物及其治疗糖尿病和肥胖症的用途
GB0902406D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL274885A (en:Method) * 1960-09-16
GB1074745A (en) 1963-07-29 1967-07-05 Sandoz Ltd Benzo[4,5]cyclohepta[1,2-b]thiophene derivatives and their preparation

Also Published As

Publication number Publication date
US4105785A (en) 1978-08-08
CH599191A5 (en:Method) 1978-05-12
GB1522457A (en) 1978-08-23
DE2710971A1 (de) 1977-09-29
FR2344284B1 (en:Method) 1979-10-05
FR2344284A1 (fr) 1977-10-14

Similar Documents

Publication Publication Date Title
JPS52139054A (en) Novel furan ringgcontaining tricyclic compounds and their preparation
IL53504A (en) Polyfluoroallyloxy compounds and their preparation
JPS5344563A (en) Preparation of benzothiazolylsulfenamide
GB1538240A (en) O-2-isocephem compounds and their preparation
PT66146A (en) Preparation of meta-aryloxy-benzaldehydes
PH13874A (en) Preparation of 6-substituted-dihydropyrams
NZ183733A (en) Preparation of 1-n-substituted-kanamycins
ZA773566B (en) Preparation of gamma-pyrones
JPS57115182A (en) Preparation of bacteriocine
IL51806A (en) Preparation of alkylthiomethyl-phenols
JPS5328168A (en) Preparation of 11phenyll33aminopyrazole
JPS52126491A (en) Preparation of polyyalphaaolefin
JPS52116427A (en) Preparation of nitrobenzole
GB1541427A (en) Preparation of hydroxysulphobetaines
JPS5331795A (en) Preparation of polyoxyalkylenee polyesterrpolysulfiddpolythiol
JPS5337666A (en) Preparation of monobenzylidenesorbitol
JPS52116463A (en) Preparation of 22oxoopyrrolidineennalkylamide
SG60983G (en) Tricyclic compounds
JPS52118460A (en) Preparation of furfural
JPS52122359A (en) Prepatation of phthalide
NZ186106A (en) Preparation of haloacylamides
GB2051045B (en) Tricyclic lactones
JPS52128367A (en) Preparation of phthalide
JPS52144667A (en) Preparation of nnchlorophalimide
ZA773195B (en) Preparation of cyanoesters